HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A comparison of three transarterial lipiodol-based formulations for hepatocellular carcinoma: in vivo biodistribution study in humans.

Abstract
This study aimed to evaluate and compare the biodistribution properties of three transarterial Lipiodol-based therapeutic regimens in human hepatocellular carcinoma (HCC). In this prospective study with 13 patients randomly allocated to one of three study groups, each of the patients received transcatheter intra-arterial administration into a solitary HCC with one of three different Lipiodol-based formulations: Lipiodol-ethanol mixture (LEM; Group A), Lipiodol alone (Group B), and Lipiodol and gelatin pledgets (Group C). With the use of radioactive iodine-131-labeled Lipiodol, each group was assessed for (1) pattern of Lipiodol accumulation in the lungs within the first 2 weeks as evaluated by single-photon emission computed tomography and (2) decomposition of Lipiodol formulation within the first 2 weeks as evaluated by radioactivity detected in peripheral blood and urine. The degree of Lipiodol retention in the tumor within the first 4 weeks was evaluated with CT. No statistically significant difference in Lipiodol accumulation in the lungs was detected among the three groups. However, the peak accumulation in the lungs was delayed 3 days for Group A compared to Groups B and C. The degree of Lipiodol retention within the tumor in Group A was significantly greater than that in Groups B and C on day 14 (p = 0.014) and day 28 (p = 0.013). This study showed that LEM is associated with a greater embolic effect in intrahepatic HCC at 4 weeks, and a comparable degree of lung shunting and decomposition rates, compared with ethanol-free Lipiodol formulations.
AuthorsSimon Chun Ho Yu, Thomas Wai Tong Leung, Wan Yee Lau, Nelson Lee, Edwin Pun Hui, Winnie Yeo, Paul Bo San Lai, Tony Shu Kam Mok
JournalCardiovascular and interventional radiology (Cardiovasc Intervent Radiol) 2008 Mar-Apr Vol. 31 Issue 2 Pg. 289-98 ISSN: 1432-086X [Electronic] United States
PMID17926090 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Contrast Media
  • Ethanol
Topics
  • Algorithms
  • Angiography, Digital Subtraction
  • Carcinoma, Hepatocellular (diagnostic imaging, therapy)
  • Chemoembolization, Therapeutic (methods)
  • Contrast Media (chemistry, pharmacokinetics)
  • Ethanol (pharmacokinetics)
  • Gelatin Sponge, Absorbable (pharmacokinetics)
  • Humans
  • Infusions, Intra-Arterial
  • Liver Neoplasms (diagnostic imaging, therapy)
  • Lung (diagnostic imaging, metabolism)
  • Prospective Studies
  • Statistics, Nonparametric
  • Tissue Distribution
  • Tomography, Emission-Computed, Single-Photon
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: